Lupin Healthcare are proud to provide high quality medicines to patients that deliver both quality and value to the NHS.
Lupin Healthcare is a subsidiary of the global pharmaceutical company Lupin Limited, where its heritage lie in generic medicines. Today’s portfolio consists of Respiratory and Neuromuscular medicines and high quality generics with a focus on anti-retroviral and oral contraceptives.
The entrepreneurial spirit, external focus and pipeline strength transitions Lupin in the UK from standard generics through to a more specialist organisation partnering with the NHS to deliver value.
Our 3 key focus areas:
HIV anti-retrovirals and oral contraceptives are key generic products in the UK with a future focus on more complex generics and biosimilars.
Lupin have launched a medicine for a rare neurological condition. Further developments in neurology are underway.
Strong Respiratory R&D expertise with products filed to deliver a future broad respiratory portfolio.
UK-LUP-2208-00003 DOP: September 2022